Pfizer's fast-acting migraine nasal spray approved by FDA

Brasil Notícia Notícia

Pfizer's fast-acting migraine nasal spray approved by FDA
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 FOX26Houston
  • ⏱ Reading Time:
  • 9 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 7%
  • Publisher: 53%

The nasal spray is designed for quick relief of migraine headaches for those who can't take pills or injections.

Zavzpret is intended to treat acute migraine symptoms; it does not prevent them.

"Among my migraine patients, one of the most important attributes of an acute treatment option is how quickly it works," said Kathleen Mullin, M.D.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

FOX26Houston /  🏆 448. in US

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Pfizer wins FDA approval for its migraine nasal sprayPfizer wins FDA approval for its migraine nasal sprayPfizer Inc. said Friday the U.S. Food and Drug Administration has approved its migraine nasal spray Zavzpret. The treatment is the first and only calcitonin...
Consulte Mais informação »

FDA approves Pfizer's new nasal spray treatment for migrainesFDA approves Pfizer's new nasal spray treatment for migrainesThe FDA approved Pfizer's newest drug on the migraine market, Zavzpret (zavegepant), the first and only migraine treatment offered in a nasal spray.
Consulte Mais informação »

US FDA approves Pfizer's pain-relief nasal spray for migraineUS FDA approves Pfizer's pain-relief nasal spray for migraineThe U.S. Food and Drug Administration on Friday approved Pfizer Inc's nasal spray for migraine, giving patients access to a potentially fast-acting pain-relief option for headaches.
Consulte Mais informação »

US FDA approves Pfizer's nasal spray for migraineUS FDA approves Pfizer's nasal spray for migraineThe U.S. Food and Drug Administration on Friday approved Pfizer Inc's nasal spray for migraine, giving patients access to a potentially fast-acting pain-relief option for headaches.
Consulte Mais informação »

FDA approves new nasal spray to treat migraine headaches in adults, Pfizer says | CNNFDA approves new nasal spray to treat migraine headaches in adults, Pfizer says | CNNThe FDA has approved a new nasal spray as a rapid treatment for migraine pain in adults. The spray may relieve pain and other migraine symptoms as soon as 15 minutes after use, drugmaker Pfizer says.
Consulte Mais informação »

Pfizer says the FDA has approved its migraine nasal spray ZavzpretDrugmaker plans to roll out the drug, which it says can relieve migraine symptoms in 30 minutes, to pharmacies in July.
Consulte Mais informação »



Render Time: 2025-02-27 08:33:32